UNI-EN 68:Notification concerning the Extraordinary General meeting of shareholders - 01.08.2018
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 68 | / | 2018 | |||||||
| Date of issue: | 2018-07-30 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification concerning the Extraordinary General meeting of shareholders - 01.08.2018 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD draws attention to the fact that the registration for participation in the Extraordinary General meeting convened on 1 August 2018 will end at 10:45 am to comply with the opening hours announced for the start of the general meeting for the convenience of all shareholders. For registration and participation in IOSA, natural persons - shareholders must present an identity document. Legal entities - shareholders must provide an original or a certified copy of a current commercial / court registration certificate as well as a legal representative's identity document. In view of the technical provision of the registration procedure for participation in the General meeting of shareholders, copies of the issued power of attorney should be submitted to the Company in hard copy or in electronic form at the latest by the end of the business day preceding the date of the General meeting, namely 17.00 on 31.07.2018. Sopharma AD will receive and accept valid electronic notices and proxies by e-mail to the following e-mail address: ir@sopharma.bg according to the instructions described in the Invitation to convene the General Meeting. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_2018_EGM_registration_espi.pdf 3JR_2018_EGM_registration_espi.pdf | Notification concerning the Extraordinary General meeting of shareholders - 01.08.2018 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2018-07-30 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 9.75 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
